2020

Lachota M, Vincenti M, Winiarska M, Boye K, Zagożdżon R, Malmberg KJ. Prospects for NK Cell Therapy of Sarcoma. Cancers (Basel). 2020 Dec 11;12(12):3719. doi: 10.3390/cancers12123719. PMID: 33322371; PMCID: PMC7763692.

Kaleta B, Mróz P, Górski A, Łukaszkiewicz J, Woźniacka A, Bogaczewicz J. The preliminay association study of osteopontin 707 C/T polymorphism with systemic lupus erythematosus in a Polish polulation. Postepy Dermatol Alergol. 2020 Apr;37(2):190-194. doi: 10.5114/ada.2019.83499. PMID: 32489353

Zielniok K, Burdzinska A, Kaleta B, Zagozdzon R, Paczek L. Vadadustat, a HIF Prolyl Hydroxylase Inhibitor, Improves Immunomodulatory Properties of Human Mesenchymal Stromal Cells. Cells. 2020 Nov 1;9(11):2396. doi: 10.3390/cells9112396. PMID: 33139632; PMCID: PMC7693843.

Janyst M, Kaleta B, Janyst K, Zagożdżon R, Kozlowska E, Lasek W. Comparative Study of Immunomodulatory Agents to Induce Human T Regulatory (Treg) Cells: Preferential Treg-Stimulatory Effect of Prednisolone and Rapamycin. Arch Immunol Ther Exp (Warsz). 2020 Jun 12;68(4):20. doi: 10.1007/s00005-020-00582-6. PMID: 32533319; PMCID: PMC7292810.

Bajor M, Graczyk-Jarzynka A, Marhelava K, Kurkowiak M, Rahman A, Aura C, Russell N, Zych AO, Firczuk M, Winiarska M, Gallagher WM, Zagozdzon R. Triple Combination of Ascorbate, Menadione and the Inhibition of Peroxiredoxin-1 Produces Synergistic Cytotoxic Effects in Triple-Negative Breast Cancer Cells. Antioxidants (Basel). 2020 Apr 16;9(4):320. doi: 10.3390/antiox9040320. PMID: 32316111; PMCID: PMC7222372.

Olszowska-Zaremba N, Gozdowska J, Sobierajska I, Zagożdżon R. Inactivation of IgM Antibodies as a Crucial Element of Diagnostics in Sensitized Patients Awaiting Kidney Transplant. Transplant Proc. 2020 Oct;52(8):2268-2272. doi: 10.1016/j.transproceed.2020.02.085. Epub 2020 Apr 1. PMID: 32247595.

Białopiotrowicz E, Noyszewska-Kania M, Kachamakova-Trojanowska N, Łoboda A, Cybulska M, Grochowska A, Kopczyński M, Mikula M, Prochorec-Sobieszek M, Firczuk M, Graczyk-Jarzynka A, Zagożdżon R, Ząbek A, Młynarz P, Dulak J, Górniak P, Szydłowski M, Pyziak K, Martyka J, Sroka-Porada A, Jabłońska E, Polak A, Kowalczyk P, Szumera-Ciećkiewicz A, Chapuy B, Rzymski T, Brzózka K, Juszczyński P. Serine Biosynthesis Pathway Supports MYC-miR-494-EZH2 Feed-Forward Circuit Necessary to Maintain Metabolic and Epigenetic Reprogramming of Burkitt Lymphoma Cells. Cancers (Basel). 2020 Mar 3;12(3):580. doi: 10.3390/cancers12030580. PMID: 32138178; PMCID: PMC7139810.

Hryniewiecka E, Hryniewiecki T, Różański J, Pilecki T, Zagożdżon R, Orłowski T, Gołębiowski M, Pączek L, Mucha K, Foroncewicz B. Reversal of stage 5 chronic kidney disease by aortic valve replacement in kidney transplant recipient: a case report. BMC Cardiovasc Disord. 2020 Jan 17;20(1):20. doi: 10.1186/s12872-020-01328-0. PMID: 31952508; PMCID: PMC6969413.

Łusiak-Szelachowska M, Weber-Dąbrowska B, Żaczek M, Borysowski J, Górski A. The Presence of Bacteriophages in the Human Body: Good, Bad or Neutral? Microorganisms. 2020 Dec 16;8(12):2012. doi: 10.3390/microorganisms8122012. PMID: 33339331; PMCID: PMC7767151.

Górski A, Borysowski J, Międzybrodzki R. Phage Therapy: Towards a Successful Clinical Trial. Antibiotics (Basel). 2020 Nov 19;9(11):827. doi: 10.3390/antibiotics9110827. PMID: 33227949; PMCID: PMC7699228.

Borysowski J, Górski A. Ethics framework for treatment use of investigational drugs. BMC Med Ethics. 2020 Nov 18;21(1):116. doi: 10.1186/s12910-020-00560-9. PMID: 33208140; PMCID: PMC7672838.

Borysowski J, Ehni HJ, Górski A. Ethics codes and medical decision making. Patient Educ Couns. 2020 Nov 1:S0738-3991(20)30595-4. doi: 10.1016/j.pec.2020.10.034. Epub ahead of print. PMID: 33189489.

Łusiak-Szelachowska M, Międzybrodzki R, Fortuna W, Borysowski J, Górski A. Anti-phage serum antibody responses and the outcome of phage therapy. Folia Microbiol (Praha). 2020 Oct 30. doi: 10.1007/s12223-020-00835-z. Epub ahead of print. PMID: 33126265.

Górski A, Borysowski J, Międzybrodzki R. Sepsis, Phages, and COVID-19. Pathogens. 2020 Oct 15;9(10):844. doi: 10.3390/pathogens9100844. PMID: 33076482; PMCID: PMC7602634.

Górski A, Międzybrodzki R, Żaczek M, Borysowski J. Phages in the fight against COVID-19? Future Microbiol. 2020 Aug;15:1095-1100. doi: 10.2217/fmb-2020-0082. Epub 2020 Aug 26. PMID: 32845164; PMCID: PMC7451411.

Borysowski J, Wnukiewicz-Kozłowska A, Górski A. Legal regulations, ethical guidelines and recent policies to increase transparency of clinical trials. Br J Clin Pharmacol. 2020 Apr;86(4):679-686. doi: 10.1111/bcp.14223. Epub 2020 Feb 19. PMID: 32017178; PMCID: PMC7098869.

Górski A, Międzybrodzki R, Węgrzyn G, Jończyk-Matysiak E, Borysowski J, Weber-Dąbrowska B. Phage therapy: Current status and perspectives. Med Res Rev. 2020 Jan;40(1):459-463. doi: 10.1002/med.21593. Epub 2019 May 7. PMID: 31062882.

2019

Zych M, Roszczyk A, Kniotek M, Kaleta B, Zagozdzon R. Sildenafil Citrate Influences Production of TNF-α in Healthy Men Lymphocytes. J Immunol Res. 2019 Oct 22;2019:8478750. doi: 10.1155/2019/8478750. PMID: 31915712; PMCID: PMC6930755.

Firczuk M, Bajor M, Graczyk-Jarzynka A, Fidyt K, Goral A, Zagozdzon R. Harnessing altered oxidative metabolism in cancer by augmented prooxidant therapy. Cancer Lett. 2020 Feb 28;471:1-11. doi: 10.1016/j.canlet.2019.11.037. Epub 2019 Dec 4. PMID: 31811907.

Marhelava K, Pilch Z, Bajor M, Graczyk-Jarzynka A, Zagozdzon R. Targeting Negative and Positive Immune Checkpoints with Monoclonal Antibodies in Therapy of Cancer. Cancers (Basel). 2019 Nov 8;11(11):1756. doi: 10.3390/cancers11111756. PMID: 31717326; PMCID: PMC6895894.

Bobrowicz M, Zagozdzon R, Domagala J, Vasconcelos-Berg R, Guenova E, Winiarska M. Monoclonal Antibodies in Dermatooncology-State of the Art and Future Perspectives. Cancers (Basel). 2019 Sep 24;11(10):1420. doi: 10.3390/cancers11101420. PMID: 31554169; PMCID: PMC6826541.

Kaleta B, Górski A, Zagożdżon R, Cieślak M, Kaźmierczak-Barańska J, Nawrot B, Klimaszewska M, Malinowska E, Górska S, Turło J. Selenium-containing polysaccharides from Lentinula edodes-Biological activity. Carbohydr Polym. 2019 Nov 1;223:115078. doi: 10.1016/j.carbpol.2019.115078. Epub 2019 Jul 13. PMID: 31427018.

Kaleta B, Krata N, Zagożdżon R, Mucha K. Osteopontin Gene Polymorphism and Urinary OPN Excretion in Patients with Immunoglobulin A Nephropathy. Cells. 2019 May 31;8(6):524. doi: 10.3390/cells8060524. PMID: 31159229; PMCID: PMC6628186.

Górski A, Międzybrodzki R, Jończyk-Matysiak E, Żaczek M, Borysowski J. Phage- specific diverse effects of bacterial viruses on the immune system. Future Microbiol. 2019 Sep;14(14):1171-1174. doi: 10.2217/fmb-2019-0222. Epub 2019 Sep 19. PMID: 31535921; PMCID: PMC6802706.

Borysowski J, Ehni HJ, Górski A. Reply to "Innovation and off-label use, the French case and more" by Braillon and Lexchin. Br J Clin Pharmacol. 2019 Oct;85(10):2448-2449. doi: 10.1111/bcp.14068. Epub 2019 Aug 13. PMID: 31410871; PMCID: PMC6783618.

Górski A, Międzybrodzki R, Jończyk-Matysiak E, Borysowski J, Letkiewicz S, Weber-Dąbrowska B. The fall and rise of phage therapy in modern medicine. Expert Opin Biol Ther. 2019 Nov;19(11):1115-1117. doi: 10.1080/14712598.2019.1651287. Epub 2019 Aug 9. PMID: 31364887.

Przybylski M, Dzieciątkowski T, Borysowski J, Międzybrodzki R, Górski A. Inhibitory Effects of Bacteriophage Preparations on Adenoviral Replication. Intervirology. 2019;62(1):37-44. doi: 10.1159/000500540. Epub 2019 Jun 12. PMID: 31189156.

Borysowski J, Górski A. Compassionate use of unauthorized drugs: Legal regulations and ethical challenges. Eur J Intern Med. 2019 Jul;65:12-16. doi: 10.1016/j.ejim.2019.04.008. Epub 2019 Apr 26. PMID: 31036436.

Górski A, Bollyky PL, Przybylski M, Borysowski J, Międzybrodzki R, Jończyk- Matysiak E, Weber-Dąbrowska B. Perspectives of Phage Therapy in Non-bacterial Infections. Front Microbiol. 2019 Jan 9;9:3306. doi: 10.3389/fmicb.2018.03306. PMID: 30687285; PMCID: PMC6333649.

Borysowski J, Ehni HJ, Górski A. Ethics codes and use of new and innovative drugs. Br J Clin Pharmacol. 2019 Mar;85(3):501-507. doi: 10.1111/bcp.13833. Epub 2019 Jan 4. PMID: 30536603; PMCID: PMC6379208.

2018

Graczyk-Jarzynka A, Goral A, Muchowicz A, Zagozdzon R, Winiarska M, Bajor M, Trzeciecka A, Fidyt K, Krupka JA, Cyran J, Szczygiel K, Efremov DG, Gobessi S, Jagielski A, Siudakowska K, Bobrowicz M, Klopotowska M, Barankiewicz J, Malenda A, Lech-Maranda E, Miazek-Zapala N, Skarzynski PH, Domagala A, Golab J, Firczuk M. Inhibition of thioredoxin-dependent H2O2 removal sensitizes malignant B-cells to pharmacological ascorbate. Redox Biol. 2019 Feb;21:101062. doi: 10.1016/j.redox.2018.11.020. Epub 2018 Nov 29. PMID: 30576925; PMCID: PMC6302138.

Urbanowicz A, Zagożdżon R, Ciszek M. Modulation of the Immune System in Chronic Hepatitis C and During Antiviral Interferon-Free Therapy. Arch Immunol Ther Exp (Warsz). 2019 Apr;67(2):79-88. doi: 10.1007/s00005-018-0532-8. Epub 2018 Nov 15. PMID: 30443787; PMCID: PMC6420452.

Eustace AJ, Conlon NT, McDermott MSJ, Browne BC, O'Leary P, Holmes FA, Espina V, Liotta LA, O'Shaughnessy J, Gallagher C, O'Driscoll L, Rani S, Madden SF, O'Brien NA, Ginther C, Slamon D, Walsh N, Gallagher WM, Zagozdzon R, Watson WR, O'Donovan N, Crown J. Development of acquired resistance to lapatinib may sensitise HER2-positive breast cancer cells to apoptosis induction by obatoclax and TRAIL. BMC Cancer. 2018 Oct 11;18(1):965. doi: 10.1186/s12885-018-4852-1. PMID: 30305055; PMCID: PMC6180577.

Bajor M, Zych AO, Graczyk-Jarzynka A, Muchowicz A, Firczuk M, Trzeciak L, Gaj P, Domagala A, Siernicka M, Zagozdzon A, Siedlecki P, Kniotek M, O'Leary PC, Golab J, Zagozdzon R. Targeting peroxiredoxin 1 impairs growth of breast cancer cells and potently sensitises these cells to prooxidant agents. Br J Cancer. 2018 Oct;119(7):873-884. doi: 10.1038/s41416-018-0263-y. Epub 2018 Oct 5. PMID: 30287919; PMCID: PMC6189216.

Burdzinska A, Dybowski B, Zarychta-Wiśniewska W, Kulesza A, Butrym M, Zagozdzon R, Graczyk-Jarzynka A, Radziszewski P, Gajewski Z, Paczek L. Intraurethral co-transplantation of bone marrow mesenchymal stem cells and muscle-derived cells improves the urethral closure. Stem Cell Res Ther. 2018 Sep 21;9(1):239. doi: 10.1186/s13287-018-0990-2. PMID: 30241573; PMCID: PMC6151032.

Bujnowska A, Michon M, Konopelski P, Hryniewiecka E, Jalbrzykowska A, Perkowska-Ptasinska A, Cieciura T, Zagozdzon R, Paczek L, Ciszek M. Outcomes of Prolonged Treatment With Intravenous Immunoglobulin Infusions for Acute Antibody-mediated Rejection in Kidney Transplant Recipients. Transplant Proc. 2018 Jul-Aug;50(6):1720-1725. doi: 10.1016/j.transproceed.2018.02.110. Epub 2018 Mar 13. PMID: 29961551.

Domagala A, Stachura J, Gabrysiak M, Muchowicz A, Zagozdzon R, Golab J, Firczuk M. Inhibition of autophagy sensitizes cancer cells to Photofrin-based photodynamic therapy. BMC Cancer. 2018 ;18(1):210.

Oei VYS, Siernicka M, Graczyk-Jarzynka A, Hoel HJ, Yang W, Palacios D, Almasbak H, Bajor M, Clement D, Brandt L, Onfelt B, Goodridge J, Winiarska M, Zagozdzon R, Olweus J, Kyte JA, Malmberg KJ. Intrinsic Functional Potential of NK-Cell Subsets Constrains Retargeting Driven by Chimeric Antigen Receptors. Cancer Immunol Res. 2018 Apr;6(4):467-480. doi: 10.1158/2326-6066.CIR-17-0207. Epub 2018 Feb 19. PMID: 29459477.

Zych AO, Bajor M, Zagozdzon R. Application of Genome Editing Techniques in Immunology. Arch Immunol Ther Exp (Warsz). 2018 Aug;66(4):289-298. doi: 10.1007/s00005-018-0504-z. Epub 2018 Jan 17. PMID: 29344676; PMCID: PMC6061149.

Górski A, Jończyk-Matysiak E, Łusiak-Szelachowska M, Międzybrodzki R, Weber- Dąbrowska B, Borysowski J, Letkiewicz S, Bagińska N, Sfanos KS. Phage Therapy in Prostatitis: Recent Prospects. Front Microbiol. 2018 Jun 29;9:1434. doi: 10.3389/fmicb.2018.01434. PMID: 30008710; PMCID: PMC6034095.

Górski A, Jończyk-Matysiak E, Międzybrodzki R, Weber-Dąbrowska B, Łusiak- Szelachowska M, Bagińska N, Borysowski J, Łobocka MB, Węgrzyn A, Węgrzyn G. Phage Therapy: Beyond Antibacterial Action. Front Med (Lausanne). 2018 May 23;5:146. doi: 10.3389/fmed.2018.00146. PMID: 29876350; PMCID: PMC5974148.

Górski A, Międzybrodzki R, Łobocka M, Głowacka-Rutkowska A, Bednarek A, Borysowski J, Jończyk-Matysiak E, Łusiak-Szelachowska M, Weber-Dąbrowska B, Bagińska N, Letkiewicz S, Dąbrowska K, Scheres J. Phage Therapy: What Have We Learned? Viruses. 2018 May 28;10(6):288. doi: 10.3390/v10060288. PMID: 29843391; PMCID: PMC6024844.

Górski A, Jończyk-Matysiak E, Międzybrodzki R, Weber-Dąbrowska B, Borysowski J. "Phage Transplantation in Allotransplantation": Possible Treatment in Graft- Versus-Host Disease? Front Immunol. 2018 Apr 27;9:941. doi: 10.3389/fimmu.2018.00941. PMID: 29755481; PMCID: PMC5933259.

Górski A, Międzybrodzki R, Jończyk-Matysiak E, Weber-Dąbrowska B, Bagińska N, Borysowski J. Perspectives of Phage-Eukaryotic Cell Interactions to Control Epstein-Barr Virus Infections. Front Microbiol. 2018 Apr 3;9:630. doi: 10.3389/fmicb.2018.00630. PMID: 29666617; PMCID: PMC5891836.

Borysowski J, Saxena A, Bateman-House A, Papaluca M, Różyńska J, Wnukiewicz- Kozłowska A, Górski A. Expanded access: growing importance to public health. J Epidemiol Community Health. 2018 Jul;72(7):557-558. doi: 10.1136/jech-2017-210409. Epub 2018 Apr 7. PMID: 29627785.

Górski A, Jończyk-Matysiak E, Łusiak-Szelachowska M, Międzybrodzki R, Weber- Dąbrowska B, Borysowski J. Phage therapy in allergic disorders? Exp Biol Med (Maywood). 2018 Mar;243(6):534-537. doi: 10.1177/1535370218755658. Epub 2018 Jan 23. PMID: 29359577; PMCID: PMC5882018.

Górski A, Jończyk-Matysiak E, Łusiak-Szelachowska M, Międzybrodzki R, Weber- Dąbrowska B, Borysowski J. The Potential of Phage Therapy in Sepsis. Front Immunol. 2017 Dec 11;8:1783. doi: 10.3389/fimmu.2017.01783. PMID: 29312312; PMCID: PMC5732260.

Górski A, Jończyk-Matysiak E, Łusiak-Szelachowska M, Weber-Dąbrowska B, Międzybrodzki R, Borysowski J. Therapeutic potential of phages in autoimmune liver diseases. Clin Exp Immunol. 2018 Apr;192(1):1-6. doi: 10.1111/cei.13092. Epub 2018 Jan 23. PMID: 29266228; PMCID: PMC5842411.

2017

Krata N, Zagożdżon R, Foroncewicz B, Mucha K. Oxidative Stress in Kidney Diseases: The Cause or the Consequence? Arch Immunol Ther Exp (Warsz). 2017 Dec 6.

Zarychta-Wiśniewska W, Burdzinska A, Zagozdzon R, Dybowski B, Butrym M, Gajewski Z, Paczek L. In vivo imaging system for explants analysis-A new approach for assessment of cell transplantation effects in large animal models. PLoS One.  2017 Sep 20;12:e0184588.

Jerzak M, Nowakowski A, Kniotek M, Górski A, Baranowski W. Decreased NK cell activity after partial vulvectomy in pregnant patient with vulvar intraepithelial neoplasia 3 (VIN3). Annals of Agricultural and Enviromental Medicine, 2017, 24 (3), 459-463

Kniotek M, Boguska A. Sildenafil Can Affect Innate and Adaptive Immune System in Both Experimental Animals and Patients. Journal of Immunology Research, 2017, 2017: 4541958

Borysowski J, Ehni H-J , Górski A. Ethics review in compassionate use. BMC Med. 2017 Jul 24;15(1):136. doi: 10.1186/s12916-017-0910-9.

PMID: 28735571Górski A, Dąbrowska K, Międzybrodzki R, Weber-Dąbrowska B, Łusiak-Szelachowska M, Jończyk-Matysiak E, Borysowski J. Phages and immunomodulation. Future Microbiol. 2017 Apr 24. doi: 10.2217/fmb-2017-0049. PubMed PMID: 28434234.

Ciszek M, Mucha K, Foroncewicz B, Żochowska D, Kosieradzki M, Grochowiecki T, Durlik M, Górski A, Pączek L. Immune biomarkers and long term graft survival: a prospective follow up of 457 kidney transplant recipients. Pol Arch Intern Med. 2017 Feb 15;127(3):178-183.

Jończyk-Matysiak E, Weber-Dąbrowska B, Żaczek M, Międzybrodzki R, Letkiewicz S, Łusiak-Szelchowska M, Górski A. Prospects of Phage Application in the Treatment of Acne Caused by Propionibacterium acnes. Front Microbiol. 2017 Feb 8;8:164. doi: 10.3389/fmicb.2017.00164. eCollection 2017. Review. PubMed PMID: 28228751

Międzybrodzki R, Kłak M, Jończyk-Matysiak E, Bubak B, Wójcik A, Kaszowska M, Weber-Dąbrowska B, Łobocka M, Górski A. Means to Facilitate the Overcoming of Gastric Juice Barrier by a Therapeutic Staphylococcal Bacteriophage A5/80. Front Microbiol. 2017 Mar 23;8:467. doi: 10.3389/fmicb.2017.00467. eCollection 2017. PubMed PMID: 28386250

Graczyk-Jarzynka A, Zagozdzon R, Muchowicz A, Siernicka M, Juszczynski P, Firczuk M. New insights into redox homeostasis as a therapeutic target in B-cell  malignancies. Curr Opin Hematol. 2017 Jul;24:393-401.

Kaleta B, Boguska A. Sildenafil, a Phosphodiesterase Type 5 Inhibitor, Downregulates Osteopontin in Human Peripheral Blood Mononuclear Cells. Arch Immunol Ther Exp (Warsz). 2017. doi: 10.1007/s00005-017-0455-9

Borysowski J, Międzybrodzki R, Wierzbicki P, Kłosowska D, Korczak-Kowalska G, Weber-Dąbrowska B, Górski A. A3R Phage and Staphylococcus aureus Lysate Do Not Induce Neutrophil Degranulation. Viruses. 2017 Feb 21;9(2). pii: E36. doi: 10.3390/v9020036

2016

Structure of Post-Transplant Care in a Single Transplant Center. Szymańska A, Pączek L, Mucha K, Krajewska M, Florczak M, Ciszek M, Sańko-Resmer J, Chmura A, Nazarewski S, Górski A, Durlik M, Krawczyk M, Foroncewicz B. Ann Transplant. 2016; 21: 194-9.

T4 Phage Tail Adhesin Gp12 Counteracts LPS-Induced Inflammation In Vivo. Miernikiewicz P, Kłopot A, Soluch R, Szkuta P, Kęska W, Hodyra-Stefaniak K, Konopka A, Nowak M, Lecion D, Kaźmierczak Z, Majewska J, Harhala M, Górski A, Dąbrowska K. Front Microbiol. 2016; 7: 1112.

Bacteriophage Procurement for Therapeutic Purposes. Weber-Dąbrowska B, Jończyk-Matysiak E, Żaczek M, Łobocka M, Łusiak-Szelachowska M, Górski A. Front Microbiol. 2016; 7: 1177.

The Effects of T4 and A3/R Bacteriophages on Differentiation of Human Myeloid Dendritic Cells. Bocian K, Borysowski J, Zarzycki M, Pacek M, Weber-Dąbrowska B, Machcińska M, Korczak-Kowalska G, Górski A. Front Microbiol. 2016; 7: 1267.

LPS-Activated Monocytes Are Unresponsive to T4 Phage and T4-Generated Escherichia coli Lysate. Bocian K, Borysowski J, Zarzycki M, Wierzbicki P, Kłosowska D, Weber-Dąbrowska B, Korczak-Kowalska G, Górski A. Front Microbiol. 2016; 7: 1356.

Antiphage activity of sera during phage therapy in relation to its outcome. Łusiak-Szelachowska M, Żaczek M, Weber-Dąbrowska B, Międzybrodzki R, Letkiewicz S, Fortuna W, Rogóż P, Szufnarowski K, Jończyk-Matysiak E, Olchawa E, Walaszek KM, Górski A. Future Microbiol. 2016

Phage Therapy: Combating Infections with Potential for Evolving from Merely a Treatment for Complications to Targeting Diseases. Górski A, Międzybrodzki R, Weber-Dąbrowska B, Fortuna W, Letkiewicz S, Rogóż P, Jończyk-Matysiak E, Dąbrowska K, Majewska J, Borysowski J. Front Microbiol. 2016;7: 1515.

Antibody Production in Response to Staphylococcal MS-1 Phage Cocktail in Patients Undergoing Phage Therapy. Żaczek M, Łusiak-Szelachowska M, Jończyk-Matysiak E, Weber-Dąbrowska B, Międzybrodzki R, Owczarek B, Kopciuch A, Fortuna W, Rogóż P, Górski A. Front Microbiol. 2016;7: 1681.

Corrigendum: Bacteriophage Procurement for Therapeutic Purposes. Weber-Dąbrowska B, Jończyk-Matysiak E, Żaczek M, Łobocka MB, Łusiak-Szelachowska M, Górski A. Front Microbiol. 2016;7: 1813.

Mesenchymal Stem Cells from Human Amniotic Membrane and Umbilical Cord Can Diminish Immunological Response in an in vitro Allograft Model. Dabrowski FA, Burdzinska A, Kulesza A, Chlebus M, Kaleta B, Borysowski J, Zolocinska A, Paczek L, Wielgos M. Gynecol Obstet Invest. 2016.

Bosek I, Kuczerowski R, Milek T, Sulich A, Kaleta B, Kniotek M, Piatkiewicz P. Evaluation of Interferon-Gamma in Patients with Type 2 Diabetes and Colorectal Cancer. J Diabetes Metab 2016, 7:1

Bosek I, Sulich A, Rabijewski M, Kaleta B, Kniotek M, Miłek T, Piątkiewicz P. Levels of interleukin-2 in patients with colon cancer and diabetes type 2. JPCCR 2016; 10(1).

2015

The Effect of Bacteriophage Preparations on Intracellular Killing of Bacteria by Phagocytes. Jończyk-Matysiak E, Łusiak-Szelachowska M, Kłak M, Bubak B, Międzybrodzki R, Weber-Dąbrowska B, Żaczek M, Fortuna W, Rogóż P, Letkiewicz S, Szufnarowski K, Górski A. J Immunol Res. 2015; 2015: 482863

Phages targeting infected tissues: novel approach to phage therapy. Górski A, Dąbrowska K, Hodyra-Stefaniak K, Borysowski J, Międzybrodzki R, Weber-Dąbrowska B. Future Microbiol. 2015; 10: 199-204

Quality and Safety Requirements for Sustainable Phage Therapy Products. Pirnay JP, Blasdel BG, Bretaudeau L, Buckling A, Chanishvili N, Clark JR, Corte-Real S, Debarbieux L, Dublanchet A, De Vos D, Gabard J, Garcia M, Goderdzishvili M, Górski A, Hardcastle J, Huys I, Kutter E, Lavigne R, Merabishvili M, Olchawa E, Parikka KJ, Patey O, Pouilot F, Resch G, Rohde C, Scheres J, Skurnik M, Vaneechoutte M, Van Parys L, Verbeken G, Zizi M, Van den Eede G. Pharm Res. 2015.

Phages in the global fruit and vegetable industry. Żaczek M, Weber-Dąbrowska B, Górski A. J Appl Microbiol. 2015; 118 (3): 537-56

Toll-like receptor 4 gene polymorphism C1196T in Polish women with postmenopausal osteoporosis: a preliminary investigation. Kaleta B, Walicka M, Sawicka A, Bogolowska-Stieblich A, Gorski A, Lukaszkiewicz J, Marcinowska-Suchowierska E. Adv Clin Exp Med 2015 (in print)

Ohams M, Jerzak M, Górski A. Effects of sildenafil citrate and etanercept treatment on TNF-α levels in peripheral blood of women with recurrent miscarriage. Ginekologia Polska, 2015, 86, 7, 520-524

2014

Possible use of bacteriophages active against Bacillus anthracis and other B. cereus group members in the face of a bioterrorism threat. Jończyk-Matysiak E, Kłak M, Weber-Dąbrowska B, Borysowski J, Górski A. Biomed Res Int. 2014; 735413

Bacteriophages displaying anticancer peptides in combined antibacterial and anticancer treatment. Dąbrowska K, Kaźmierczak Z, Majewska J, Miernikiewicz P, Piotrowicz A, Wietrzyk J, Lecion D, Hodyra K, Nasulewicz-Goldeman A, Owczarek B, Górski A. Future Microbiol. 2014; 9(7): 861-9

Immunogenicity studies of proteins forming the T4 phage head surface. Dąbrowska K, Miernikiewicz P, Piotrowicz A, Hodyra K, Owczarek B, Lecion D, Kaźmierczak Z, Letarov A, Górski A. J Virol. 2014; 88 (21): 12551-7

Facing antibiotic resistance: Staphylococcus aureus phages as a medical tool. Kaźmierczak Z, Górski A, Dąbrowska K. Viruses. 2014; 6 (7): 2551-70

Phage neutralization by sera of patients receiving phage therapy. Łusiak-Szelachowska M, Zaczek M, Weber-Dąbrowska B, Międzybrodzki R, Kłak M, Fortuna W, Letkiewicz S, Rogóż P, Szufnarowski K, Jończyk-Matysiak E, Owczarek B, Górski A. Viral Immunol. 2014; 27 (6): 295-304

In vitro design of a novel lytic bacteriophage cocktail with therapeutic potential against organisms causing diabetic foot infections. Mendes JJ, Leandro C, Mottola C, Barbosa R, Silva FA, Oliveira M, Vilela CL, Melo-Cristino J, Górski A, Pimentel M, São-José C, Cavaco-Silva P, Garcia M. J Med Microbiol. 2014; 63(Pt 8): 1055-65

Taking bacteriophage therapy seriously: a moral argument. Verbeken G, Huys I, Pirnay JP, Jennes S, Chanishvili N, Scheres J, Górski A, De Vos D, Ceulemans C. Biomed Res Int. 2014; 2014: 621316.

Molecular imaging of T4 phage in mammalian tissues and cells. Kaźmierczak Z, Piotrowicz A, Owczarek B, Hodyra K, Miernikiewicz P, Lecion D, Harhala M, Górski A, Dąbrowska K. Bacteriophage. 2014; 4(1): e28364.

Association between Fok I vitamin D receptor gene (VDR) polymorphism and impulsivity in alcohol-dependent patients. Wrzosek M, Jakubczyk A, Wrzosek M, Kaleta B, Łukaszkiewicz J, Matsumoto H, Brower K, Nowicka G, Wojnar M. Mol Biol Rep. 2014; 41(11):7223-8.

Role of osteopontin in systemic lupus erythematosus. Kaleta B. Arch Immunol Ther Exp (Warsz). 2014; 62(6):475-82 

2013

The dysfunction of NK cells in patients with type 2 diabetes and colon cancer. Piątkiewicz P, Miłek T, Bernat-Karpińska M, Ohams M, Czech A, Ciostek P. Arch Immunol Ther Exp (Warsz). 2013; 61(3): 245-53.

Toll-like receptor 4 gene polymorphism 1196 C/T does not influence the risk of neuropsychiatric systemic lupus erythematosus in Polish population--a preliminary report. Bogaczewicz A, Sobow T, Bogaczewicz J, Kaleta B, Sysa-Jedrzejowska A, Robak E, Lukaszkiewicz J, Dariusz S, Wozniacka A. Lupus. 2013; 22(14):1504-8.

Vitamin D Receptor Gene BsmI Polymorphism in Polish Patients with Systemic Lupus Erythematosus. Kaleta B, Bogaczewicz J, Robak E, Sysa-Jędrzejowska A, Wrzosek M, Szubierajska W, Mróz P, Lukaszkiewicz J, Woźniacka A. ISRN Endocrinol. 2013: 427818

Vitamin D receptor gene polymorphism Fok I in the Polish population does not contribute to the risk of systemic lupus erythematosus. Bogaczewicz J, Kaleta B, Sysa-Jedrzejowska A, Robak E, Lukaszkiewicz J, Sitkiewicz D, Wozniacka A. Lupus. 2013; 22(7):750-1

CD4⁺ CD25⁺ FOXP3⁺ regulatory T cells in peripheral blood and peritoneal fluid of patients with endometriosis. Olkowska-Truchanowicz J, Bocian K, Maksym RB, Białoszewska A, Włodarczyk D, Baranowski W, Ząbek J, Korczak-Kowalska G, Malejczyk J. Hum Reprod. 2013; 28(1): 119-24.

2012

Phage as a modulator of immune responses: practical implications for phage therapy. Górski A, Międzybrodzki R, Borysowski J, Dąbrowska K, Wierzbicki P, Ohams M, Korczak-Kowalska G, Olszowska-Zaremba N, Łusiak-Szelachowska M, Kłak M, Jończyk E, Kaniuga E, Gołaś A, Purchla S, Weber-Dąbrowska B, Letkiewicz S, Fortuna W, Szufnarowski K, Pawełczyk Z, Rogóż P, Kłosowska D. Adv Virus Res. 2012; 83: 41-71.

Etanercept immunotherapy in women with a history of recurrent reproductive failure. Jerzak M, Ohams M, Górski A, Baranowski W. Ginekol Pol. 2012; 83(4): 260-4

The expression of particular glucose transporters and insulin resistance indicators in the risk groups of type 2 diabetes--a two-year follow-up. Bernat-Karpińska M, Piątkiewicz P, Czech A, Wierzbicki P. Endokrynol Pol. 2012; 63(3):212-9.